Huang Yimin,Xu Weijue,Wu Yibo,et al.Diagnosis and treatment of catheter-related bloodstream infection of totally implantable venous access ports in children: a report of four cases[J].Journal of Clinical Pediatric Surgery,,19():939-942,956.[doi:10.3969/j.issn.1671-6353.2020.10.015]
Click Copy

Diagnosis and treatment of catheter-related bloodstream infection of totally implantable venous access ports in children: a report of four cases

References:

1 Shankar G,Jadhav V,Ravindra S,et al.Totally implantable venous access devices in children requiring long-term chemotherapy:analysis of outcome in 122 children from a single institution[J].Indian J Surg Oncol,2016,7(3):326-331.DOI 10.1007/s13193-015-0485-x.
2 Zhou J,Qian SK,He WX,et al.Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer[J].World J Surg Oncol,2014,12:378.DOI:10.1186/1477-7819-12-378.
3 Young SJ,Young LJ,Vogel J,et al.Accessing totally implantable venous assess systems on the day of placement does not significantly increase the risk of infection[J].J Vasc,2016,17(3):261-264.DOI:10.5301/jva.5000505.
4 Maristela B,Gustavo U,Franklin C,et al.Hemodialysis catheter-related infection:prophylaxis,diagnosis and treatment[J].J Vasc Access,2015,16(5):347-355.DOI:10.5301/jva.5000368.
5 Caterina G,Maria A,Alessandro C.Totally implantable venous access devices in children with medical complexity:preliminary data from a tertiary care hospital[J].J Vasc Access,2017,18(5):426-429.DOI:10.5301/jva.5000727.
6 Michelle RV,Luciana SL,Lauded CA.Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port:A cohort study[J].Pediatr Blood Cancer,2017,64(2):336-342.DOI:10.1002/pbc.26225.
7 Yoshida J,Harada Y,Kikuchi T,et al.Does antimicrobial use density at the ward level influence monthly central line-associated bloodstream infection rates?[J].Infect Drug Resist,2014,7:331-335.DOI:10.2147/IDR.S74347.
8 Giorgio SS,Kátia C,Lenzi AV,et al.Biofilm formation in catheter-related infections by Panton-Valentine leukocidin-producing Staphylococcus aureus[J].Int Microbiol,2016,19(4):199-207.DOI:10.2436/20.1501.01.278.
9 Nuria FH,Benito A.Antibiotic-lock therapy:a clinical viewpoint[J].Expert Rev Anti Infect Ther,2014,12(1):117-129.DOI:10.1586/14787210.2014.863148.
10 Messing B,Peitra-Cohen S,Debure A,et al.Antibiotic-lock technique:a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients[J].JPEN J Parenteral Enteral Nutr,1988,12(2):185-189.DOI:10.1177/0148607188012002185.
11 Corbella M,Brandolini M,Cambieri P,et al.A catheter-related bloodstream infection caused by Chryseobacterium indologenes successfully treated with antibiotic-lock rescue therapy[J].New Microbiol,2017,40(3):223-225.
12 Soman R,Gupta N,Suthar M,et al.Antibiotic lock therapy in the era of Gram-negative resistance[J].J Assoc Physicians India,2016,64(2):32-37.
13 Fernandez HN,Almirante B.Antibiotic-lock therapy:a clinical viewpoint[J].Expert Rev Anti Infect Ther,2014,12(1):117-129.DOI:10.1586/14787210.2014.863148.
14 Issam R,Hend H.Intravascular catheter-related infections:advances in diagnosis,prevention and management[J].Lancet Infect Dis,2007,7(10):645-657.DOI:10.1016/S1473-3099(07)70235-9.
15 Viana T,Lima LS,Araújo CC,et al.Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port:A cohort study[J].Pediatr Blood Cancer,2017,64(2):336-342.DOI:10.1002/pbc.26225.
16 Walz JM,Memtsoudis SG,Heard SO.Prevention of central venous catheter bloodstream infections[J].J Intensive Care Med,2010,25(3):131-138.DOI:10.1177/0885066609358952.

Memo

收稿日期:2018-08-19。
通讯作者:刘江斌,Email:ljbin888@163.com

Last Update: 2020-10-28